IGMS — IGM Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for IGM Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	225	366	230	427	338
Net Total Receivables	0.035	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	231	373	241	438	348
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18	34.8	56.3	73.1	74
Long Term Investments
Other Long Term Assets
Total Assets	261	409	298	513	423
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.88	17.2	27.8	44.7	42.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.1	26.8	53.2	226	220
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	240	382	245	287	203
Total Liabilities & Shareholders' Equity	261	409	298	513	423
Total Common Shares Outstanding